US FDA approves Gilead cancer gene therapy; price set at $373000Reuters These 5 Top Stocks Are Moving Late On News: S&P 500 FuturesInvestor’s Business Daily Move over, Novartis: Kite and Gilead break into CAR-T market with early axi-cel nodFiercePharma UPDATED: FDA follows through with a groundbreaking OK for Yescarta, Gilead’s new CAR-T breakthroughEndpoints News FDA […]
Business
Gilead cancer immunotherapy wins US approval with $373000 price
Gilead cancer immunotherapy wins US approval with $373000 priceNasdaq The FDA just approved a revolutionary gene-modification treatmentQuartz Kite Nabs First Adult CAR-T Approval With Notable Uptick Of CuresXconomy UPDATED: FDA follows through with a groundbreaking OK for Yescarta, Gilead’s new CAR-T breakthroughEndpoints News Cutting-edge immunotherapy treatment approved for another deadly cancerWashington Post Full coverage
Ford to recall 1.34 million trucks in North America for door latch fix
Ford to recall 1.34 million trucks in North America for door latch fixReuters Ford door-latch issues expand to trucksMarketWatch Ford to Recall About 1.3 Million Trucks in North America for Door Latch FixU.S. News & World Report Full coverage
Ford to recall about 1.3 million trucks in North America for door latch fix
Ford to recall about 1.3 million trucks in North America for door latch fixReuters Ford door-latch issues expand to trucksMarketWatch Ford to Take $267 Million Hit From Recall of F-Series TrucksBloomberg Full coverage
Ford to Take $267 Million Hit From Recall of F-Series Trucks
Ford to Take $267 Million Hit From Recall of F-Series TrucksBloomberg Ford door-latch issues expand to trucksMarketWatch Ford recalls 1.3M F-150, Super Duty trucks in North AmericaWDIV Detroit Full coverage